Review The SDS Document
DOWNLOADProduct Details
Formula
C12H9F3N2O2
MW
270.21
Purity
>97%
Solubility (DMSO Mg/MI)
30
Bio Chemical Notes
Initial results from the phase III clinical trials for the treatment of MS, are promising. Teriflunomide blocks the proliferation and function of activated T and B lymphocytes via inhibition of a critical mitochondrial enzyme. Ref: Multiple Sclerosis Resource Center.